Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.807 USD | 0.00% | +4.67% | +41.58% |
May. 14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
May. 14 | Viracta Therapeutics, Inc. Appoints Michael Faerm as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.58% | 31.69M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- Lenz Therapeutics, Graphite Bio Complete Merger; Combined Company Names New CFO